Physician profile
Raphael E Nwojo
NPI 1891083689
$6,492.74
in general payments reported to CMS, 2019-2025
20 companies · $973 in 2025
The $973 reported for 2025 was more than what 79% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,492 · 2020: $271 · 2021: $367 · 2022: $917 · 2023: $2,030 · 2024: $443 · 2025: $973.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,976 · Food and Beverage: $1,436 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,975.79 |
| Food and Beverage | $1,436.44 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $2,007.17 | 2022-2025 | Inspire |
| Medtronic, INC. | $1,229.79 | 2022-2025 | Propel, Nuvent, Sinuva |
| Stryker Corporation | $714.85 | 2019-2021 | |
| Medical Device Business Services, INC. | $701.96 | 2019 | |
| Glaxosmithkline, LLC. | $429.82 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $319.53 | 2022-2025 | Dupixent |
| Acclarent, INC | $239.75 | 2019-2024 | Relieva Spinplus |
| Cochlear Americas | $148.98 | 2019 | |
| Intersect Ent, INC. | $146.76 | 2019 | |
| Advanced Bionics, LLC | $121.43 | 2022-2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Astrazeneca Pharmaceuticals Lp | $104.49 | 2019-2025 | Tezspire |
| Smith+Nephew, INC. | $91.27 | 2019-2024 | Tula |
| Alphatec Spine, INC | $69.00 | 2021 | |
| Genzyme Corporation | $46.16 | 2024-2025 | |
| Amgen INC. | $34.00 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $21.49 | 2023 | |
| Novartis Pharmaceuticals Corporation | $18.42 | 2019 | |
| Axogen | $18.11 | 2025 | |
| Merck Sharp & Dohme LLC | $17.05 | 2025 | Keytruda |
| Olympus America INC. | $12.71 | 2023 | Rhino-Laryngo Videoscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphael Nwojo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.